PEG-Modified Spidroins for Biomimetic Spider Silk Spinning
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Recombinant spidroins lacking one or both terminal domains are incapable of reproducing the molecular mechanisms of native spider silk spinning, necessitating non-native methods for structural transition to β-sheet structures.
Innovation Solution
Chemical modification of recombinant spidroins through bioconjugation with polyethylene glycol polymers, specifically using 2- to 8-arm polyethylene glycol maleimide (PEG-Mal), enables the production of spider silk-like fibers by NT-mediated dimerization at low pH.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of manufacture
If recombinant spidroins lack terminal domains to simplify production, then ease of manufacture is improved, but the ability to reproduce native silk spinning mechanisms is lost
Solution Approach 1:
The invention extracts only the essential N-terminal domain (NT) and repetitive region (Rep) from the full spidroin sequence, omitting the C-terminal domain (CT). This minimal construct NT-(Rep)x-C maintains the ability to undergo pH-mediated dimerization and β-sheet formation while simplifying production. The extracted NT domain contains the critical dimerization interface and pH-responsive elements needed for biomimetic spinning.
Solution Approach 2:
The invention utilizes pH as a critical parameter to trigger dimerization and fiber formation. By lowering the pH to approximately 5.5, the NT domain undergoes conformational change and dimerizes, initiating the assembly process. This pH-mediated transition replicates the natural spinning mechanism without requiring the full terminal domains, enabling biomimetic fiber production from simplified constructs.
2Productivity
If non-native coagulation methods are used to form β-sheet structures, then fiber production is achieved, but the biomimetic nature of the process is lost
Solution Approach 1:
The NT-(Rep)x-C construct is designed to undergo self-assembly through pH-mediated dimerization and spontaneous β-sheet formation. The repetitive region contains inherent propensity for β-sheet structure, and the NT domain provides self-complementary dimerization interfaces. This self-service mechanism replicates nature's spinning process, eliminating the need for external coagulation agents or non-native processing steps.
Solution Approach 2:
The invention exploits the pH-induced phase transition of the NT domain from monomeric soluble state to dimeric assembled state. This phase transition triggers the cascade of events leading to β-sheet formation and fiber assembly, mirroring the natural spinning process where pH changes in the spider silk gland initiate fiber formation. The transition is controlled by environmental pH rather than external coagulation methods.
3Reliability
If both terminal domains are included in recombinant spidroins, then biomimetic fiber formation is achieved, but device complexity increases
Solution Approach 1:
The invention extracts only the functionally essential N-terminal domain and repetitive region, removing the C-terminal domain from the construct. The NT domain alone provides sufficient dimerization capability and pH-responsiveness for biomimetic fiber formation. This extraction simplifies the genetic construct while preserving the core spinning mechanism, reducing complexity without sacrificing functionality.
Solution Approach 2:
The invention segments the spidroin molecule into functional modules: the NT domain for dimerization and pH-response, the repetitive region for β-sheet formation, and a minimal C-terminal cysteine for anchoring. This segmentation allows the minimal NT-(Rep)x-C construct to perform all essential functions independently, eliminating the need for the full-length CT domain and simplifying the overall construct design.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Artificial spider silk fibers are produced in a biomimetic manner, demonstrating high solubility and spinning capability without organic solvents, suitable for use in regenerative medicine and cell culture scaffolds.
Implementation Method 1
the NT dimerizes and becomes stabilized, thereby firmly interconnecting the spidroins
Implementation Method 2
CT unfolds and forms amyloid-like fibrils that may function as nucleation seeds facilitating the conversion of the repetitive region to β-sheet structures
Implementation Method 3
The structural transition of the spidroins from soluble dope to solid fibers is mediated by changes in pH and ion composition of the aqueous environment
Implementation Method 4
Disulfide bond reduction to obtain free thiol groups with tris(2-carboxyethyl)phosphine (TCEP)
Implementation Method 5
Coupling with 2- to 8-arm polyethylene glycol maleimide (PEG-Mal)
Data Source
AI summary
The present invention relates to recombinant spidroin bioconjugates (chemically modified engineered spider silk proteins). More particularly, the invention relates to recombinant spidroin bioconjugates with poly-ethyleneglycol polymers and their use in regenerative medicine.